Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Kenneth W. Mahaffey

ResearcherPublications, citations & collaboration network

Kenneth W. Mahaffey is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,040 works, 101,308 citations, an h-index of 134 and an i10-index of 531.

1,040
Works
101,308
Citations
134
h-index
531
i10-index

How has Kenneth W. Mahaffey's publication output changed over time?

ScholarIQpublication output · 2008–2024

Output grew0% over the shown period — from 1 works in 2008 to 1 in 2024.

1
1
1
1
1
2
3
1
1
200820092011201220172018201920222024

What are the most-cited papers on Kenneth W. Mahaffey?

ScholarIQmost cited works
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg, Guohua Pan, Daniel E. Singer, Werner Hacke, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, John F. Paolini, Scott D. Berkowitz, Keith A.A. Fox, Robert M. Califf
New England Journal of Medicine. 20119,441 CitationsOPEN ACCESS
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R. Matthews
New England Journal of Medicine. 20177,831 CitationsOPEN ACCESS
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin, Richard C. Becker, Andrzej Budaj, Christopher P. Cannon, Håkan Emanuelsson, Claes Held, Jay Horrow, Steen Husted, Stefan James, Hugo A. Katus, Kenneth W. Mahaffey, Benjamin M. Scirica, Allan M. Skene, Philippe Gabríel Steg, Robert F. Storey, Robert A. Harrington
New England Journal of Medicine. 20097,106 CitationsOPEN ACCESS
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Authors Task Force Members, Philippe Gabríel Steg, Stefan James, Dan Atar, Luigi P. Badano, Carina Blomstrom Lundqvist, Michael A. Borger, Carlo Di Mario, Kenneth Dickstein, Grégory Ducrocq, Francisco Fernández‐Avilés, Anthony Gershlick, Pantaleo Giannuzzi, Sigrun Halvorsen, Kurt Huber, Peter Jüni, Adnan Kastrati, Juhani Knuuti, Mattie Lenzen, Kenneth W. Mahaffey, Marco Valgimigli, Arnoud van't Hof, Petr Widimský, Doron Zahger, Jeroen J. Bax, Helmut Baumgartner, Claudio Ceconi, Veronica Dean, Christi Deaton, RH Fagard, C. Funck-Brentano, David Hasdai, Arno Hoes, Paulus Kirchhof, Juhani Knuuti, P Kolh, Theresa McDonagh, Moulin Ch, Bogdan A. Popescu, Z Reiner, Udo Sechtem, Per Anton Sirnes, Michal Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Document Reviewers, David Hasdai, Felicity Astin, Karin Åström-Olsson, Andrzej Budaj, Peter Clemmensen, Jean-Philippe Collet, Keith A. Fox, Ahmet Fuat, O Gustiene, Christian W. Hamm, Petr Kala, Patrizio Lancellotti, Aldo Pietro Maggioni, Béla Merkely, Franz-Josef Neumann, Massimo F. Piepoli, Frans Van de Werf, FREEK VERHEUGT, Lars Wallentin
European Heart Journal. 20126,847 CitationsOPEN ACCESS
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal, Séverine Bompoint, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, Christopher P. Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M. Brenner, Kenneth W. Mahaffey
New England Journal of Medicine. 20196,091 CitationsOPEN ACCESS

Related on ScholarIQ

Cardiovascular Institute of the South
Institution
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Paper
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Paper
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Paper
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Paper
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Paper
470M+ articles · free account